You are viewing: Europe Therapeutic Hypothermia Systems Market analysis

The Europe Therapeutic Hypothermia Systems Market was valued at $86 Million in 2023 and projected to reach to $111.8 Million by 2028, representing a compound annual growth rate of 5.4%. Europe's therapeutic hypothermia systems market is poised for steady expansion through 2028, driven by rising incidence of cardiac arrest and stroke cases, coupled with strengthening clinical guidelines endorsing hypothermia protocols.

Europe Therapeutic Hypothermia Systems Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Therapeutic Hypothermia Systems Market Trends and Insights

  • In Europe, the adoption of therapeutic hypothermia technologies is driven by increasing prevalence of cardiac arrest, stroke, and traumatic brain injury cases, alongside growing clinical evidence supporting neuroprotective outcomes.
  • Europe's advanced healthcare infrastructure, stringent regulatory frameworks, and high healthcare spending create a favorable environment for market expansion. The European market benefits from strong institutional support and widespread integration of hypothermia protocols in intensive care units across major economies.
  • Europe continues to witness rising demand for both intravascular and surface cooling systems as hospitals prioritize post-resuscitation care standards.
  • Between 2023 and 2028, Europe is expected to see accelerated adoption driven by clinical guideline updates, reimbursement improvements, and technological innovations in temperature management devices..

Key Market Statistics

  • CAGR (2023-2028) 5.4% CAGR
  • Market Size, 2023 ~USD 86 Million
  • Forecast, 2028 ~USD 111.8 Million
  • Geography Europe

Europe Therapeutic Hypothermia Systems Market Overview

Market Valuation :

Europe's therapeutic hypothermia systems market reached $86.0 million in 2023, with steady growth projected to $111.8 million by 2028, driven by advanced healthcare infrastructure and regulatory support across the region.

Germany's Market Leadership :

Germany dominates the European market with a valuation of $39.2 million, reflecting strong adoption of therapeutic hypothermia technologies in cardiac care and neurological treatment protocols across leading medical institutions.

Clinical Evidence Adoption :

Growing clinical evidence supporting neuroprotection in cardiac arrest, stroke, and traumatic brain injury cases is accelerating technology adoption across European hospitals and specialized care centers.

Regional Growth Trajectory :

Europe's 5.4% CAGR (2023-2028) reflects moderate but consistent expansion, supported by increasing prevalence of acute neurological conditions and rising healthcare expenditure across developed European economies.

Europe Therapeutic Hypothermia Systems Market Dynamics

  • The region's mature healthcare infrastructure, high adoption rates of advanced medical technologies, and robust reimbursement frameworks support market growth.
  • Germany, UK, and France lead adoption, with increasing investment in critical care capabilities and neurological treatment centers.
  • Regulatory harmonization through CE marking and European medical device directives facilitates market entry and standardization.
  • However, growth remains moderate compared to global rates, reflecting market saturation in developed nations and cost constraints in some healthcare systems..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Europe's therapeutic hypothermia systems market reached $86.0 million in 2023 with a projected value of $111.8 million by 2028.
    • Europe demonstrates a 5.4% CAGR, reflecting steady adoption of temperature management technologies in critical care settings.
    • In Europe, advanced healthcare infrastructure and strong clinical evidence support widespread integration of hypothermia protocols in ICUs.
    • Europe's market growth is fueled by rising cardiac arrest cases, improved reimbursement policies, and technological innovations in cooling systems.

    Therapeutic Hypothermia Systems Market Report Scope

    Report Metric Details
    Base Year 2023
    Fastest Growing Segment CARDIOLOGY (Application)
    Forecast Period 2023-2028
    Growth Rate CAGR of 6.3% from 2023 to 2028
    Largest Segment COOLING DEVICES (Product)
    Market Size Base Year (Billions) ~USD 0.29 (2023)
    Revenue Forecast (Billions) ~USD 0.4 (2028)
    Segments Covered Product, Application, Volume

    Europe Therapeutic Hypothermia Systems Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Cool Caps
    • Cooling Catheters
    • Cooling Devices

    By Application

    • Cardiology
    • Neonatal Care
    • Neurology
    • Other Applications

    By Volume

    • Cooling Devices

    REST OF EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028

    Segment20212022202320242025202620272028CAGR (%)
    CARDIOLOGY2.62.72.833.13.33.43.65.2
    NEONATAL CARE0.40.40.40.40.50.50.50.54.6
    NEUROLOGY3.33.53.63.73.83.94.24.23.1
    OTHER APPLICATIONS0.30.30.30.30.30.30.30.45.9
    TOTAL6.66.97.17.47.788.48.74.1

    EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028

    Segment20212022202320242025202620272028CAGR (%)
    CARDIOLOGY31.633.535.337.339.441.744.146.85.8
    NEONATAL CARE5.45.76.16.26.67.17.37.64.5
    NEUROLOGY36.638.640.142.244.446.649.351.85.3
    OTHER APPLICATIONS3.94.24.54.64.74.95.15.64.5
    TOTAL77.5828690.395.1100.3105.8111.85.4

    Target Audience

    • Medical Device Manufacturers : Manufacturers need Europe-specific market data to develop localized product strategies, navigate CE marking requirements, and identify high-growth country markets like Germany for therapeutic hypothermia system expansion.
    • Healthcare Providers & Hospitals : Hospital administrators and critical care directors require market insights to benchmark technology adoption rates, justify capital investments in hypothermia systems, and align procurement with clinical evidence and regional trends.
    • Investment & Private Equity Firms : Investors evaluating European healthcare technology opportunities need detailed market sizing, growth forecasts, and regional dynamics to assess portfolio companies and identify acquisition targets in the therapeutic hypothermia sector.
    • Regulatory & Policy Bodies : European health authorities and policy makers use market data to understand technology adoption patterns, inform reimbursement policies, and develop clinical guidelines for therapeutic hypothermia in cardiac and neurological care.
    • Consultants & Market Strategists : Business consultants advising healthcare organizations need Europe-specific market intelligence to develop market entry strategies, competitive positioning, and growth plans for therapeutic hypothermia system providers.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 161.7 Million · 6.2% wtd CAGR ·
    Asia Pacific
    ~USD 93.9 Million · 8.3% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    GermanyUSD 39.2 Million
    UKUSD 14.9 Million
    FranceUSD 14.6 Million
    ItalyUSD 7.8 Million
    SpainUSD 6.5 Million
    Rest Of EuropeUSD 5.2 Million

    Country market size visualization

    Germany
    USD 39.2 Million
    UK
    USD 14.9 Million
    France
    USD 14.6 Million
    Italy
    USD 7.8 Million
    Spain
    USD 6.5 Million
    Rest Of Europe
    USD 5.2 Million

    Reasons to Buy this Report

    • Regional Market Segmentation : Gain detailed insights into Europe's $86 million market with country-level breakdowns including Germany ($39.2M), UK ($14.9M), and France ($14.6M), enabling targeted market entry and expansion strategies.
    • Growth Forecasting : Access 5-year projections through 2028 showing expansion to $111.8 million, helping stakeholders plan product launches, capacity investments, and market positioning in Europe's therapeutic hypothermia sector.
    • Competitive Landscape Intelligence : Understand Europe-specific adoption drivers, regulatory requirements, and clinical practice patterns that differentiate the region from global markets, informing competitive strategy and product development.
    • Healthcare System Insights : Leverage analysis of European healthcare infrastructure, reimbursement models, and clinical guidelines to identify market opportunities and optimize go-to-market approaches across diverse healthcare systems.
    • Investment Decision Support : Make informed investment and partnership decisions with comprehensive data on Europe's moderate but stable 5.4% CAGR, market maturity levels, and growth catalysts in cardiac and neurological care.

    Frequently asked questions

    What is the current size of Europe's therapeutic hypothermia systems market?

    Europe's therapeutic hypothermia systems market was valued at $86.0 million in 2023 and is expected to grow to $111.8 million by 2028.

    What is the projected growth rate for Europe's therapeutic hypothermia market?

    Europe's therapeutic hypothermia systems market is projected to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2028.

    What factors are driving growth in Europe's therapeutic hypothermia market?

    Growth in Europe is driven by increasing cardiac arrest and stroke cases, strong clinical evidence for neuroprotection, advanced healthcare infrastructure, improved reimbursement policies, and technological innovations in temperature management systems.

    Which European countries are leading the therapeutic hypothermia systems market?

    Europe's largest markets include Germany, France, the United Kingdom, and Scandinavia, where advanced healthcare systems and high adoption rates of critical care protocols support market expansion.

    What types of therapeutic hypothermia systems are used in Europe?

    Europe utilizes both intravascular cooling systems and surface cooling devices, with hospitals increasingly adopting integrated temperature management solutions for post-resuscitation care and neuroprotection.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the therapeutic hypothermia systems market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

    The four steps involved in estimating the market size are

    Collecting Secondary Data

    The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. A database of the key industry leaders was also prepared using secondary research.

    Collecting Primary Data

    The primary research data was conducted after acquiring knowledge about the market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as pharmaceutical & biotechnology industries, food & nutraceutical industries, and research laboratories) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

    A breakdown of the primary respondents is provided below:

    Breakdown of Primary Participants:

    Therapeutic Hypothermia  Systems Market Size, and Share

    Note 1: *Others include sales managers, marketing managers, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    All major product manufacturers offering various therapeutic hypothermia systems were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value therapeutic hypothermia systems market was also split into various segments and subsegments at the region and country level based on:

    • Product mapping of various manufacturers for each type of market at the regional and country level 
    • Relative adoption pattern of each market among key application segments at the regional and/or country-level 
    • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
    • Detailed secondary research to gauge the prevailing market trends at the regional and/or country level 

    Global Therapeutic Hypothermia Systems Market Size: Top-Down Approach

    Therapeutic Hypothermia  Systems Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Global Therapeutic Hypothermia Systems Market Size: Bottom-Up Approach

    Therapeutic Hypothermia  Systems Market Size, and Share

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Therapeutic hypothermia systems industry.

    Market Definition

    Therapeutic hypothermia, also known as targeted temperature management or induced hypothermia, is a medical treatment that involves lowering a patient’s body temperature for a specific period to provide therapeutic benefits. This intervention is often employed in certain medical conditions to reduce the risk of injury to tissues, particularly the brain, and improve overall outcomes. The primary goal of therapeutic hypothermia is to protect the body’s organs, especially the brain, from damage following events such as cardiac arrest, traumatic brain injury, stroke, or neonatal hypoxic-ischemic encephalopathy (a type of brain injury that occurs when there is a lack of oxygen and blood flow to the brain in newborns).

    Key Stakeholders

    • Senior Management
    • Finance/Procurement Department
    • R&D Department
    • Surgeons and Anesthesiologists/Paramedical Staff/Nursing Staff

    Report Objectives

    • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To define, describe, segment, and forecast the therapeutic hypothermia systems market by product, application, and region
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
    • To forecast the size of the market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Rest of the world.
    • To profile key players in the market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the market.
    • To benchmark players within the market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

    Available Customizations

    MarketsandMarkets offers the following customizations for this market report:

    • Additional country-level analysis of the Therapeutic hypothermia systems market
    • Profiling of additional market players (up to 5)

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Therapeutic hypothermia systems Market

    Get the Full Therapeutic Hypothermia Systems Market Report

    Full forecast, segment splits, and company analysis for all Therapeutic Hypothermia Systems Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status